In Brief: ImmunoTherapeutics
Executive Summary
ImmunoTherapeutics: Michael Rosen to president and CEO. He succeeds Gerald Vosika, PhD, who continues as chairman and chief scientific officer. Rosen previously served as president and CEO of the Spanish biotech Pharma Mar and has held positions at Searle, Bristol-Myers Squibb and Pfizer...